Yahoo Finance

Immunic, Inc. (IMUX)

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...
Yahoo Finance

Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December

NEW YORK, Nov. 26, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases ...
Yahoo Finance

Immunic, Inc. (IMUX) Stock Major Holders - Yahoo Finance

VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. 69.93k Sep 30, 2025 0.06% 46,881 SCHWAB CAPITAL TRUST-Schwab Total Stock Market Index Fund 25k Jul 31, 2025 0.02% 16,760 ...
Yahoo Finance

Immunic, Inc. (IMUX)

VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. 69.93k Sep 30, 2025 0.06% 46,818 SCHWAB CAPITAL TRUST-Schwab Total Stock Market Index Fund 25k Jul 31, 2025 0.02% 16,737 ...
Stocks Telegraph

Immunic, Inc. (IMUX) Climbs 5.8% in Pre-market Trading: Following Conference Participation Announcement

Summary • Immunic, Inc. (IMUX) rises 5.8% in pre-market trading ahead of a healthcare conference. • CEO Daniel Vitt to participate in a chat at the Evercore ISI Healthcare Conference o 4, 2025. • Year ...
Yahoo Finance

Immunic, Inc. (IMUX)

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 p.m. to 4 a.m. ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...